FDA
-
-
-
-
-
-
-
AEON Biopharma receives second NYSE American listing notice
-
-
-
-
-
-
-
AEON Biopharma names John Bencich as chief financial officer
-
-
-
-
-
-
-
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
-
-
-
-
-
-
-
AEON Biopharma (AEON) Announces NYSE American Acceptance of Plan to Regain Listing Compliance
-
-
-
-
-
-
-
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
AEON Biopharma (AEON) Prices 40M Unit Offering at $0.50/unit
-
-
-
-
-
-
-
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
-
325,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

